Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare

Detalles Bibliográficos
Autores principales: Lal, Amos, Dang, Johnny, Nabzdyk, Christoph, Gajic, Ognjen, Herasevich, Vitaly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577733/
https://www.ncbi.nlm.nih.gov/pubmed/36267783
http://dx.doi.org/10.21037/atm-22-4203
_version_ 1784811824095428608
author Lal, Amos
Dang, Johnny
Nabzdyk, Christoph
Gajic, Ognjen
Herasevich, Vitaly
author_facet Lal, Amos
Dang, Johnny
Nabzdyk, Christoph
Gajic, Ognjen
Herasevich, Vitaly
author_sort Lal, Amos
collection PubMed
description
format Online
Article
Text
id pubmed-9577733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-95777332022-10-19 Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare Lal, Amos Dang, Johnny Nabzdyk, Christoph Gajic, Ognjen Herasevich, Vitaly Ann Transl Med Editorial AME Publishing Company 2022-09 /pmc/articles/PMC9577733/ /pubmed/36267783 http://dx.doi.org/10.21037/atm-22-4203 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial
Lal, Amos
Dang, Johnny
Nabzdyk, Christoph
Gajic, Ognjen
Herasevich, Vitaly
Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare
title Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare
title_full Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare
title_fullStr Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare
title_full_unstemmed Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare
title_short Regulatory oversight and ethical concerns surrounding software as medical device (SaMD) and digital twin technology in healthcare
title_sort regulatory oversight and ethical concerns surrounding software as medical device (samd) and digital twin technology in healthcare
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577733/
https://www.ncbi.nlm.nih.gov/pubmed/36267783
http://dx.doi.org/10.21037/atm-22-4203
work_keys_str_mv AT lalamos regulatoryoversightandethicalconcernssurroundingsoftwareasmedicaldevicesamdanddigitaltwintechnologyinhealthcare
AT dangjohnny regulatoryoversightandethicalconcernssurroundingsoftwareasmedicaldevicesamdanddigitaltwintechnologyinhealthcare
AT nabzdykchristoph regulatoryoversightandethicalconcernssurroundingsoftwareasmedicaldevicesamdanddigitaltwintechnologyinhealthcare
AT gajicognjen regulatoryoversightandethicalconcernssurroundingsoftwareasmedicaldevicesamdanddigitaltwintechnologyinhealthcare
AT herasevichvitaly regulatoryoversightandethicalconcernssurroundingsoftwareasmedicaldevicesamdanddigitaltwintechnologyinhealthcare

Ejemplares similares